The hazards of cross comparing the drug toxicity results from different trials in metastatic renal cancer: in response to a letter from Dr. Catalá-López

MeSH terms

• Antineoplastic Agents / adverse effects*
• Carcinoma, Hepatocellular / therapy*
• Carcinoma, Renal Cell / drug therapy*
• Carcinoma, Renal Cell / pathology*
• Female
• Humans
• Indoles / adverse effects*
• Kidney Neoplasms / drug therapy*
• Kidney Neoplasms / pathology*
• Liver Neoplasms / therapy*
• Male
• Pyrimidines / adverse effects*
• Pyrroles / adverse effects*
• Sulfonamides / adverse effects*